Prostate Cancer Recurrence: Genomic Clues
- PMID: 28148485
- DOI: 10.1158/2159-8290.CD-NB2017-016
Prostate Cancer Recurrence: Genomic Clues
Abstract
In the largest genomic analysis of intermediate-risk prostate cancer samples to date, researchers have uncovered a five-element molecular signature that could help pinpoint patients whose disease is likely to recur and metastasize even after surgery or radiotherapy. They hope to develop a prognostic assay from this signature that can be used in the clinic.
©2017 American Association for Cancer Research.
Comment on
-
Genomic hallmarks of localized, non-indolent prostate cancer.Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9. Nature. 2017. PMID: 28068672
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
